Page 10 - Domestic Markets

Spice row: Govt plans greater scrutiny, guidelines on use of ethylene oxide

ETO, a flammable, colourless gas is generally used as a disinfectant, sterilising agent as well as an insecticide to reduce microbial contamination in spices

FPIs domiciled at GIFT City allowed to issue P-notes to investors

Move could boost issuance and drive flows into domestic markets, say experts

Pre-election rally has more legs; stay cautious in small-caps: Apurva Sheth

The Sensex to SmallCap ratio is trading near its lowest levels since 2008. This means that smallcaps have outperformed relative to large-caps, Apurva Sheth said in this interview

RIL to boost homegrown Wyzr brand in Indian consumer electronics market

Mukesh Ambani's company aims to open its own manufacturing plants, expanding Wyzr's product range to include TVs, washing machines, refrigerators

Markets to focus on Budget, US Fed policy in eventful week, say analysts

Interim budget, the US Federal policy decision and quarterly earnings will be the major drivers for stock markets which may also see some consolidation this week, say analysts. Besides, investors would also focus on the trading activity of foreign investors and global trends for further cues. From the macroeconomic front, the PMI (Purchasing Managers' Index) data for the manufacturing sector is scheduled to be announced on Thursday. Finance Minister Nirmala Sitharaman will present the interim budget for 2024-25 on February 1 (Thursday). The Federal Open Market Committee meeting will be held on January 30 and 31. "Market is likely to consolidate further ahead of the US Fed interest rate decision where the Fed is expected to maintain status quo and give some hint with regards to rate cut timeline. Apart from this, BoE (Bank of England) monetary policy is also due coupled with a few key economic data releases which might keep markets volatile. "Further many heavyweights would be ...

Zero-duty unrefined gold imports take the shine off local players

Some refineries stayed away from giving an undertaking to govt. for not importing unrefined gold from LDCs

Markets soar on dovish US Federal Reserve, Sensex settles atop 70K

US 10-yr treasury yield now below 4% as risk appetite increases

Key overhang removed, focus to shift on earnings, liquidity: Brokerages

Results give message of political continuity and 'augur well' for macroeconomics, say brokerages

Vanguard to Goldman Sachs, global firms rush to buy Alipay's Zomato stakes

Shares of Zomato have nearly doubled this year as the company started to turn a profit after going public in 2021, prompting some of its biggest investors to lock in gains on their investments

Medicines for four rare diseases become cheaper due to domestic production

Medicines for four rare diseases have become available at drastically cheaper rates as Indian pharma companies are now producing them reducing the reliance on expensive imported formulations, Union Health Ministry officials said on Friday. The slashing of prices comes as the ministry has prioritised action related to 13 rare diseases along with sickle cell anaemia. Drugs for four of these diseases -Tyrosinemia Type 1, Gaucher's Disease, Wilson's Disease and Dravet-Lennox Gastaut Syndrome - along with sickle cell Anemia have been approved and are being manufactured indigenously. Four more drugs for three diseases - Tablet Sapropterin for Phenylketonuria, tab Sodium Phenyl Butyrate and tablet Carglumic Acid for Hyperammonemia and Capsule Miglustat for Gaucher's disease - are under process for approval and are likely to be available by April 2024, official sources said. With these drugs being manufactured indigenously, the annual cost of Nitisinone capsules, used in the treatment of .

Markets rise for 3rd day as bond yields soften; Sensex, Nifty up nearly 1%

The Fed's dovish comments rekindled hopes of its rate-hiking campaign ending and spurred an equity rally across the globe

Markets rebound after Fed holds rates steady; Sensex rises 490 points

US bond yields retreat on signs the Federal Reserve may be done with tightening

A tidal wave of capital

With India poised to see a surge in domestic market inflows, the focus must shift to maximising the benefits for the economy

Manufacturing sentiment positive in first quarter, shows Ficci survey

In the fourth quarter of FY23, 55 per cent of the respondents reported higher production levels

India's manufacturing PMI softens slightly to 57.8 in June from 58.7 in May

'Client interest' continues to support industry and helping growth of output and employment, it says

Nifty 500 vs S&P 500: India catches its breadth, even as US outruns it

On the surface, it appears that the US markets have done exceedingly well. However, a deeper analysis reveals the gains in the domestic market to be more well-spread

IDFC FIRST Bank raises Rs 1,500 crore via Tier-2 bonds in domestic market

Face value of Rs 1 cr, coupon rate 8.4%; paper has a tenure of 10 years with call option at the end of five years

Centre to release tur from national buffer till imported stocks arrive

The order has also made it mandatory for entities to declare the stock position on the relevant portal of the Department of Consumer Affairs

Rupee rises 6 paise to 82.54 against US dollar in early trade on Monday

The rupee gained 6 paise to 82.54 against the US dollar in early trade on Monday, tracking positive trends in domestic and global markets as well as inflows of foreign funds. The dollar index is trading almost flat at 104 level with forex traders awaiting an agreement on the US debt ceiling between US President Joe Biden and Republican House Speaker Kevin McCarthy. At the interbank foreign exchange, the domestic unit opened stronger at 82.57 against the dollar and hit the highest level of 82.51. Later, it slipped to 82.54, registering a gain of 6 paise over its previous close. On Friday, the rupee closed at 82.60 against the US currency. Anand James, Chief Market Strategist at Geojit Financial Services, said in his rupee outlook that the Indian currency is likely to reach the level of 82.25 against the US currency. "Inability to float above 82.70 has elevated the risk of revisit of 82.45. Breach of the same may expose 82.2. Until this holds, we may pull back into the sideways tren

Zerodha's co-founder, Nikhil Kamath is backing on domestic consumption

Nikhil Kamath explains to his followers why India's domestic consumption market is the place to be in the coming decade